IL17A and tuberculosis: This is consistent with previous studies showing Th17 cells to be protective during latent phase of infection while reduced IL17 levels during TB correlates with poor disease outcome27,28 and the proportion of pathogenic Th17 cells to directly correlate with clinical parameters associated with disease severity29,30.